Since the $87 million HEALing Communities Study was announced just over a year ago, the University of Kentucky and its community and state partners have been working diligently to lay the groundwork to get the project up and running.

By Josh Shepherd

Four members of the Surgery faculty were surprised at Surgery Grand Rounds Wednesday morning, May 13, when department chair Dr. William B. Inabnet III proudly announced that they were approved for promotion. The honors came nearly six months earlier than usual, said Dr. Inabnet.

A group of University of Kentucky professors and scientists efforts to identify possible direct therapeutic approaches to treat COVID-19 was published in the Perspectives section of the most recent issue of Science, a journal of the American Association for the Advancement of Science (AAAS).

The University of Kentucky’s Sanders-Brown Center on Aging has been a leader in Alzheimer’s Disease related research for many years. The success seen at Sanders-Brown can be directly attributed to the people within the center.

“UK is fantastic at many things, but when it comes to driving the science and the search for cures for diseases like Alzheimer’s, we are second to none,” said Dr. Greg Jicha.

@UK_Colorectal
@UKyGenSurgery

By Josh Shepherd

The Division of General Surgery received approval from the Accreditation Council of Graduate Medical Education (ACGME) in May to expand their class of General Surgery residents from seven to eight and to establish a new Colon and Rectal Surgery (CRS) Fellowship program beginning in the 2020-21 academic year.

Clinical leaders from the University of Kentucky’s Markey Cancer Center, College of Medicine and College of Pharmacy have launched a clinical trial for experimental therapies to treat patients infected with COVID-19. The trial will investigate the effectiveness of azithromycin, ivermectin and camostat mesylate—drugs that could inhibit replication of SARS-CoV-2, the virus that causes the disease.

NIH HEAL InitiativeSM’s research is testing system to link incarcerated women to outside opioid use disorder services before leaving jail.

The Department had ten publications listed in PubMed for the month of April 2020.

1: Han R, Hensley PJ, Li J, Zhang Y, Stark TW, Heller A, Qian H, Shi J, Liu Z, Huang JA, Jin T, Wei X, Zhou BP, Wu Y, Kyprianou N, Chen J, Yang XH. Integrin-associated CD151 is a suppressor of prostate cancer progression. Am J Transl Res. 2020 Apr 15;12(4):1428-1442. eCollection 2020. PubMed PMID: 32355552; PubMed Central PMCID: PMC7191174.